We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$39.5B
AUM Growth
+$3.42B
Cap. Flow
+$4.94B
Cap. Flow %
12.5%
Top 10 Hldgs %
10.56%
Holding
4,400
New
1,066
Increased
1,336
Reduced
1,179
Closed
749

Sector Composition

Rank Sector Weight
1 Energy 15.14%
2 Healthcare 12.64%
3 Financials 8.59%
4 Utilities 7.75%
5 Technology 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORAN
4051
DELISTED
Orange
ORAN
-235,398
Closed -$3.72M
DXYN
4052
DELISTED
Dixie Group Inc
DXYN
-16,400
Closed -$174K
AAMC
4053
DELISTED
Altisource Asset Management Corp
AAMC
-3,216
Closed -$1.37M
ASXC
4054
DELISTED
Asensus Surgical, Inc.
ASXC
-2,190
Closed -$144K
SPWR
4055
DELISTED
SunPower Corporation Common Stock
SPWR
-155,012
Closed -$4.16M
TWOU
4056
DELISTED
2U Inc
TWOU
-1,916
Closed -$966K
SLCA
4057
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-289,200
Closed -$16M
WIRE
4058
DELISTED
Encore Wire Corp
WIRE
-4,664
Closed -$229K
THMO
4059
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
-6
Closed -$73K
SP
4060
DELISTED
SP Plus Corporation
SP
-27,511
Closed -$588K
TRVN
4061
DELISTED
Trevena, Inc.
TRVN
-16
Closed -$57K
NBSE
4062
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-50
Closed -$190K
EIGR
4063
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-27
Closed -$195K
EXPR
4064
CALL
DELISTED
Express, Inc.
EXPR
-2,500
Closed -$852K
BPTH
4065
DELISTED
Bio-Path Holdings Inc
BPTH
-47
Closed -$570K
CIR
4066
DELISTED
CIRCOR International, Inc
CIR
-63,442
Closed -$4.89M
NATI
4067
DELISTED
National Instruments Corp
NATI
-18,820
Closed -$610K
NUVA
4068
PUT
DELISTED
NuVasive, Inc.
NUVA
-154,900
Closed -$5.51M
PDCE
4069
CALL
DELISTED
PDC Energy, Inc.
PDCE
-128,200
Closed -$8.1M
KBAL
4070
DELISTED
Kimball International
KBAL
-63,196
Closed -$825K
BSMX
4071
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-197,547
Closed -$2.62M
AGRX
4072
DELISTED
Agile Therapeutics
AGRX
-56
Closed -$975K
CNCE
4073
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-20,676
Closed -$209K
AGTC
4074
DELISTED
Applied Genetic Technologies Corporation
AGTC
-32,468
Closed -$750K
ZEN
4075
DELISTED
ZENDESK INC
ZEN
-76,194
Closed -$1.32M

Similar funds

Israel Englander's Q3 2014 Portfolio in Review

As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.

By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.

  • Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
  • Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
  • Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
  • Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
  • Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
  • Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
  • Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.

Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.